Phenomenon or Process – Page 2

FDA Union Prepares for Negotiations as HHS Job Cuts Reshape Workforce

6 months ago talkbio0Tagged Advocacy, CHARGE Syndrome, employee layoffs, federal, Force, layoffs, Mediation, public health medicine (field), reduction in force, restructuring, Union, United States Food and Drug Administration

FDA layoffs, HHS restructuring, Union negotiations, Reduction in Force (RIF), Robert F. Kennedy Jr., FDA workforce reduction, HHS employee layoffs, Federal health agencies, Public health impact, Union advocacy

Former CBER head Peter Marks says he blocked RFK Jr. from vaccine safety database before leaving FDA: AP

6 months ago talkbio0Tagged Disease Outbreaks, Kennedy, Kennedy 's, Massive, Peter Marks, RFK Jr., United States Food and Drug Administration, Vaccine Safety, Vaccines, VAERS

Vaccines, Massive, Vaccine Safety, Kennedy, United States Food and Drug Administration, RFK Jr., Disease Outbreaks, Peter Marks, VAERS, Kennedy ‘s

RFK Jr. promotes measles vaccine as Texas outbreak continues

6 months ago talkbio0Tagged Case (situation), Disease Outbreaks, Effectiveness, Measles, Measles-Mumps-Rubella Vaccine, RFK gene, Texas, Vaccination, Vaccines

Vaccines, Texas, Measles, Disease Outbreaks, Measles-Mumps-Rubella Vaccine, Case (situation), RFK gene, Effectiveness, Vaccination, Texas

ImmuneOnco axes CD47 bispecific as pipeline prioritization pressures hit Chinese biotech

7 months ago talkbio0Tagged CD47 Antigen, China, ImmuneOnco

CD47 Antigen, ImmuneOnco, China

Sofinnova Partners Launches Three New Biotechs with €165M Acceleration Fund

7 months ago talkbio0Tagged Acceleration, BioClec, Funds, Partner in relationship, pharmaceutical backing, Sofinnova, venture

Sofinnova Partners, biotech acceleration fund, BioClec, Forth Therapeutics, Signadori Bio, venture capital, pharmaceutical backing

RFK Jr. Backtracks on Vaccine Pledge, Announces Review of Childhood Immunization Schedule

8 months ago talkbio0Tagged CHARGE Syndrome, childhood vaccine schedule, Confirmation, Disease Outbreaks, measles, public health medicine (field), Robert F. Kennedy, Secretary, Senate

Robert F. Kennedy Jr., HHS Secretary, childhood vaccine schedule, review, controversy, public health, measles outbreak, Senate confirmation

Boehringer Ingelheim’s Nerandomilast Achieves Second Phase III Success in Pulmonary Fibrosis Treatment

8 months ago talkbio0Tagged Boehringer, FIBRONEER-ILD, Force, Idiopathic Pulmonary Fibrosis, Ingelheim, nerandomilast, Phase 3 Clinical Trials, Progressive, Pulmonary Fibrosis, Respiratory physiology, Vital capacity

Nerandomilast, Boehringer Ingelheim, Phase III trial, FIBRONEER-ILD, progressive pulmonary fibrosis, idiopathic pulmonary fibrosis, lung function, forced vital capacity